Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Clustran
Sumatriptan succinate 16.8mg/mL
equivalent to sumatriptan 12mg/mL (6mg/0.5mL)
Solution for injection
Actavis New Zealand Limited
Sun Pharmaceutical Industries Limited, Halol, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Solifenacin Actavis
Solifenacin succinate 5mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Solifenacin Actavis
Solifenacin succinate 10mg
Film coated tablet
Actavis New Zealand Limited
Actavis ehf, Hafnarfjordur, Iceland
|
Dated this 14th day of October 2016.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz